There are 360 resources available
233P - Tumor characteristics of mixed response upon immune checkpoint inhibition (ICI) in advanced melanoma
Presenter: Judith Versluis
Session: Poster Display
234P - Oncolytic adenovirus-based therapeutics to reprogram the glioblastoma microenvironment for improved CAR T cell therapy
Presenter: Jana de Sostoa PomŽs
Session: Poster Display
235P - Multiplexed Imaging Reveals the Immunomodulatory cGAS as a Predictor of Response in Patients With Malignant Pleural Mesothelioma
Presenter: Alexander Laure
Session: Poster Display
236P - A novel microfluidic platform for understanding the role of PDAC stroma in immune response
Presenter: Marlene Geyer
Session: Poster Display
237P - Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: a joint analysis of OnCovid and ESMO-CoCARE registries
Presenter: Alessio Cortellini
Session: Poster Display
238P - Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors
Presenter: Giulia Mazzaschi
Session: Poster Display
239P - Survival outcomes predicted by irAEs on 18F-FDG-PET in response to PD-1 antibody therapy in metastatic melanoma
Presenter: Sarah Lewis
Session: Poster Display
240P - AMU: Using mRNA Embedding in Transformer Network to Predict Melanoma Immune Checkpoint Inhibitor Response
Presenter: Yi Yin
Session: Poster Display
242P - Educational needs of healthcare professionals using immune checkpoint inhibitors across multiple tumour types: A cross-speciality survey
Presenter: Judy Brownsword
Session: Poster Display